Survey of US Living Kidney Donation and Transplantation Practices in the COVID-19 Era
Survey of US Living Kidney Donation and Transplantation Practices in the COVID-19 Era
复制标题
DOI：
10.1016/j.ekir.2020.08.017
复制
发表时间：
2020-11-01
影响因子：
6
通讯作者：
Axelrod, David A.
中科院分区：
文献类型：
--
作者：
Lentine, Krista L.;Vest, Luke S.;Axelrod, David A.
2019冠状病毒病（COVID-19）大流行对活体肾移植（LDKT）实践的影响范围尚未明确。方法：我们调查了美国的移植项目，以评估COVID-19大流行期间活体LDKT的做法、策略和障碍。经机构审查委员会批准后，该调查于2020年5月9日至2020年5月30日通过电子邮件和发布到专业学会列表服务器分发。根据各州COVID-19累积发病率进行分层。结果：118个中心的工作人员做出了回应，代表了大流行前一年美国活体供体恢复计划的61%和LKDT量的75%。总体而言，66%的人报告说，LDKT手术被搁置了（COVID-19累积发病率“高”州为81%，“低”州为49%）。总共有36%的人报告说，对新的捐助者候选人的评估已经暂停，27%的人报告说，评估大大减少了
Introduction: The scope of the impact of the coronavirus disease 2019 (COVID-19) pandemic on living donor kidney transplantation (LDKT) practices is not well defined.Methods: We surveyed US transplant programs to assess practices, strategies, and barriers to living LDKT during the COVID-19 pandemic. After institutional review board approval, the survey was distributed from 9 May 2020 to 30 May 2020 by e-mail and postings to professional society list-servs. Responses were stratified based on state COVID-19 cumulative incidence levels.Results: Staff at 118 unique centers responded, representing 61% of US living donor recovery programs and 75% of LKDT volume in the prepandemic year. Overall, 66% reported that LDKT surgery was on hold (81% in "high" vs. 49% in "low" COVID-19 cumulative incidence states). A total of 36% reported that evaluation of new donor candidates had paused, 27% reported that evaluations were very much decreased (>0% to